BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27798875)

  • 1. Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance.
    Suzuki S; Okada M; Kuramoto K; Takeda H; Sakaki H; Watarai H; Sanomachi T; Seino S; Yoshioka T; Kitanaka C
    Anticancer Res; 2016 Oct; 36(10):5153-5161. PubMed ID: 27798875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.
    Sanomachi T; Suzuki S; Kuramoto K; Takeda H; Sakaki H; Togashi K; Seino S; Yoshioka T; Okada M; Kitanaka C
    Anticancer Res; 2017 Nov; 37(11):6177-6188. PubMed ID: 29061799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.
    Jiang C; Lee SH; Park JH; Lee JS; Park JW; Kim JR; Lee SH; Kim HS; Yoon S
    Anticancer Res; 2021 Feb; 41(2):687-697. PubMed ID: 33517273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
    Chen G; Xu S; Renko K; Derwahl M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro.
    Badran A; Tul-Wahab A; Zafar H; Mohammad N; Imad R; Ashfaq Khan M; Baydoun E; Choudhary MI
    PLoS One; 2020; 15(8):e0235676. PubMed ID: 32746451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.
    Novi F; Millan MJ; Corsini GU; Maggio R
    J Neurochem; 2007 Aug; 102(4):1410-24. PubMed ID: 17532788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release.
    Aihara K; Shimada J; Miwa T; Tottori K; Burris KD; Yocca FD; Horie M; Kikuchi T
    Brain Res; 2004 Apr; 1003(1-2):9-17. PubMed ID: 15019558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.
    Kato T; Mizoguchi Y; Monji A; Horikawa H; Suzuki SO; Seki Y; Iwaki T; Hashioka S; Kanba S
    J Neurochem; 2008 Jul; 106(2):815-25. PubMed ID: 18429930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2008 Nov; 597(1-3):27-33. PubMed ID: 18831971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone.
    Ma GF; Raivio N; Sabrià J; Ortiz J
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
    Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
    Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells.
    Roney MSI; Park SK
    Arch Pharm Res; 2018 Apr; 41(4):384-408. PubMed ID: 29556831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
    Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.
    Yeh CT; Wu AT; Chang PM; Chen KY; Yang CN; Yang SC; Ho CC; Chen CC; Kuo YL; Lee PY; Liu YW; Yen CC; Hsiao M; Lu PJ; Lai JM; Wang LS; Wu CH; Chiou JF; Yang PC; Huang CY
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1180-8. PubMed ID: 23024022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antipsychotic aripiprazole induces antinociceptive effects: Possible role of peripheral dopamine D2 and serotonin 5-HT1A receptors.
    Almeida-Santos AF; Ferreira RC; Duarte ID; Aguiar DC; Romero TR; Moreira FA
    Eur J Pharmacol; 2015 Oct; 765():300-6. PubMed ID: 26325094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma.
    Kang MK; Kang SK
    Stem Cells Dev; 2007 Oct; 16(5):837-47. PubMed ID: 17999604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.